Metadata Search
Abbott Japan
Page 1 of 13 results
Sort by: relevance publication year Download as CSV

Independent association of HLA-DPB1*02:01 with rheumatoid arthritis in Japanese populations

Journal Article published 20 Sep 2018 in PLOS ONE volume 13 issue 9 on page e0204459

Research funded by Japan Society for the Promotion of Science (26293123, 22591090, 18K08402, 24791018, 15K09543) | Takeda Science Foundation | Mitsui Sumitomo Insurance Welfare Foundation | Eisai | Astellas Pharma | Takeda Pharmaceutical Company | Abbott Japan | Mitsubishi Tanabe Pharma | the ministry of health, labour, and welfare of japan | Chugai Pharmaceutical | national hospital organization | Japan Research Foundation for Clinical Pharmacology | Nakatomi Foundation | Bristol-Myers KK | MSD K.K. | Teijin Pharma | Daiwa Securities Health Foundation | Pfizer Japan | Japan Agency for Medical Research and Development

Authors: Hiroshi Furukawa, Shomi Oka, Kota Shimada, Atsushi Hashimoto, Akiko Komiya, Shinichiro Tsunoda, Akiko Suda, Satoshi Ito, Koichiro Saisho, Masao Katayama, Satoshi Shinohara, Takeo Sato, Katsuya Nagatani, Seiji Minota, Toshihiro Matsui, Naoshi Fukui, Shoji Sugii, Hajime Sano, Kiyoshi Migita, Shouhei Nagaoka, Shigeto Tohma

Editors: Qizhai Li

Characteristics of nighttime reflux assessed using multichannel intraluminal impedance pH monitoring and a portable electroencephalograph

Journal Article published 21 Jan 2015 in Diseases of the Esophagus volume 29 issue 3 on pages 278 to 284

Research funded by Otsuka | Eisai | Astellas Pharma US | Abbott Japan | Takeda Pharmaceuticals U.S.A. | Dainippon Sumitomo | Daiichi-Sankyo | Ministry of Education, Culture, Sports, Science and Technology

Authors: Y. Fujiwara, Y. Kohata, K. Nakahara, T. Tanigawa, H. Yamagami, M. Shiba, K. Watanabe, K. Tominaga, T. Watanabe, T. Arakawa

Biomarker for nontuberculous mycobacterial pulmonary disease in patients with rheumatoid arthritis: Anti-glycopeptidolipid core antigen immunoglobulin A antibodies

Journal Article published 6 Jul 2017 in Modern Rheumatology volume 28 issue 2 on pages 271 to 275

Research funded by Takeda Science Foundation | Mitsui Sumitomo Insurance Welfare Foundation | Bristol-Myers Squibb | Astellas Pharma Inc. | Pfizer Japan Inc. | Mitsuibishi Tanabe Pharma Corporation | Eisai Co., Ltd. | the Ministry of Health, Labour, and Welfare of Japan | Clinical Research from National Hospital Organization | The Nakatomi Foundation | Takeda Pharmaceutical Company | Practical Research Project for Allergic Diseases and Immunology | Japan Society for the Promotion of Science, Health and Labour Science Research | Abbott Japan | Bristol-Myers K.K. RA Clinical Investigation | Japan Research Foundation for Clinical Pharmacology | Teijin Pharma Limited | Chugai Pharmaceutical Co., Ltd | Research (25670458) | Daiwa Securities Health Foundation | Merck Sharp and Dohme Inc. | Young Scientists (24791018) | Japan Agency for Medical Research and Development | Grants-in-Aid for Scientific Research (22390199, 26293123, 22591090)

Authors: Kanako Iwata, Shomi Oka, Hirotaka Tsuno, Hiroshi Furukawa, Kota Shimada, Atsushi Hashimoto, Akiko Komiya, Naoyuki Tsuchiya, Masao Katayama, Shigeto Tohma

Tulobuterol inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells

Journal Article published Aug 2013 in Physiological Reports volume 1 issue 3

Research funded by Health, Labour Welfare Sciences Research | Abbott Japan | Japanese Government

Authors: Mutsuo Yamaya, Hidekazu Nishimura, Lusamba Nadine, Hiroshi Kubo, Nagatomi Ryoichi

Human Leukocyte Antigen and Systemic Sclerosis in Japanese: The Sign of the Four Independent Protective Alleles, DRB1*13:02, DRB1*14:06, DQB1*03:01, and DPB1*02:01

Journal Article published 26 Apr 2016 in PLOS ONE volume 11 issue 4 on page e0154255

Research funded by Japan Society for the Promotion of Science (26293123, 22591090, 24791018) | Takeda Science Foundation | Mitsui Sumitomo Insurance Welfare Foundation | Astellas Pharma Inc. | Pfizer Japan Inc. | National Hospital Organization | Mitsuibishi Tanabe Pharma Corporation | Chugai Pharmaceutical Co., Ltd. | Eisai Co., Ltd. | the Ministry of Health, Labour, and Welfare of Japan | Kato Memorial Trust for Nambyo Research | The Nakatomi Foundation | Takeda Pharmaceutical Company | Abbott Japan | Japan Research Foundation for Clinical Pharmacology | Teijin Pharma Limited | Daiwa Securities Health Foundation | Merck Sharp and Dohme Inc.

Authors: Hiroshi Furukawa, Shomi Oka, Aya Kawasaki, Kota Shimada, Shoji Sugii, Takashi Matsushita, Atsushi Hashimoto, Akiko Komiya, Naoshi Fukui, Kouji Kobayashi, Atsumu Osada, Atsushi Ihata, Yuya Kondo, Tatsuo Nagai, Keigo Setoguchi, Akiko Okamoto, Akira Okamoto, Noriyuki Chiba, Eiichi Suematsu, Hajime Kono, Masao Katayama, Shunsei Hirohata, Takayuki Sumida, Kiyoshi Migita, Minoru Hasegawa, Manabu Fujimoto, Shinichi Sato, Shouhei Nagaoka, Kazuhiko Takehara, Shigeto Tohma, Naoyuki Tsuchiya

Editors: Shervin Assassi

High rate of improvement in serum matrix metalloproteinase-3 levels at 4 weeks predicts remission at 52 weeks in RA patients treated with adalimumab

Journal Article published 2 May 2017 in Modern Rheumatology volume 28 issue 1 on pages 119 to 125

Research funded by UCB | Mitsubishi Tanabe Pharmaceutical | Pfizer | AbbVie | Bristol-Myers Squibb | Daiichi-Sankyo | Eisai | Mitsubishi Tanabe Pharma Corporation | AYUMI Pharmaceutical | Kaken Pharmaceutical | Hisamitsu Pharmaceutical | Astellas Pharma | Janssen Pharmaceutical | Abbott Japan | Taisho Toyama Pharmaceutical Company | Mitsubishi Tanabe Pharma | Takeda Pharmaceutical Compan | Chugai Pharmaceutical | Janssen Pharmaceuticals | Daiichi Sankyo Company | Takeda Pharmaceutical | Otsuka Pharmaceutical

Authors: Yosuke Hattori, Toshihisa Kojima, Atsushi Kaneko, Daihei Kida, Yuji Hirano, Takayoshi Fujibayashi, Yuichiro Yabe, Takeshi Oguchi, Yasuhide Kanayama, Hiroyuki Miyake, Takefumi Kato, Hideki Takagi, Masatoshi Hayashi, Takayasu Ito, Tomone Shioura, Nobunori Takahashi, Hisato Ishikawa, Koji Funahashi, Naoki Ishiguro

Determinants of short and long door-to-balloon time in current primary percutaneous coronary interventions

Journal Article published 20 Nov 2017 in Heart and Vessels volume 33 issue 5 on pages 498 to 506

Research funded by Abbott Japan (Speaking honoraria, served as a consultant) | Boston Scientific Japan (speaking honoraria, served as a proctor, served as a consultant) | Medtronic Cardiovascular (Speaking honoraria) | Terumo (Speaking honoraria) | OrbusNeich (Speaking honoraria) | Daiichi-Sankyo (Speaking honoraria) | Sanofi Japan (Speaking honoraria) | NIPRO (Speaking honoraria) | Mehergen Group Holdings, Inc (served as a consultant)

Authors: Takunori Tsukui, Kenichi Sakakura, Yousuke Taniguchi, Kei Yamamoto, Hiroshi Wada, Shin-ichi Momomura, Hideo Fujita

A novel synonymous variant in the F8 gene, p.(Leu40=)/c.120C>A, likely causes mild haemophilia A

Journal Article published Jul 2018 in Haemophilia volume 24 issue 4 on pages e289 to e292

Research funded by Baxalta | Japan Society for the Promotion of Science (JP25461461) | Pfizer | Torii Pharmaceutical | Save the Redwoods League | Kaketsuken | CSL Behring | Japan Blood Products | Roche Diagnostic | CMIC | Abbott Japan | Chugai Pharmaceutical | Biogen | Bioverativ | Novo Nordisk | Octapharma | Bayer | Sekisui Medical | Japan Agency for Medical Research and Development | Life Sciences Institute

Authors: H. Inaba, K. Shinozawa, K. Fukutake, K. Amano

Change in type of sleep-disordered breathing from predominant central to obstructive sleep apnea following coronary artery bypass grafting

Journal Article published Sep 2017 in Journal of Cardiology Cases volume 16 issue 3 on pages 93 to 96

Research funded by Ministry of Health, Labor and Welfare of Japan (26507010) | Pfizer | Bristol-Myers Squibb | Astrazeneca K.K. | Astellas Pharma Inc. | Kirin Co. Ltd. | Takeda Pharmaceutical Company | Abbott Japan | Bayer Yakuhin, Ltd | Daiichi Sankyo Company | Sanofi K.K. | Boston Scientific Japan K.K. | MSD K.K. | Philips Respironics | Kaken Pharmaceutical Co., Ltd.

Authors: Shoichiro Yatsu, Takatoshi Kasai, Hiroki Matsumoto, Azusa Murata, Takao Kato, Shoko Suda, Masaru Hiki, Nanako Shiroshita, Mitsue Kato, Fusae Kawana, Hiroyuki Daida

Additional treatment with clarithromycin reduces fever duration in patients with influenza

Journal Article published Sep 2014 in Respiratory Investigation volume 52 issue 5 on pages 302 to 309

Research funded by Abbott Japan | Taisho Toyama Pharmaceutical Co., Ltd.

Authors: Fuyuhiko Higashi, Hiroshi Kubo, Hiroyasu Yasuda, Toshihiro Nukiwa, Mutsuo Yamaya